{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01056471",
      "OrgStudyIdInfo": {
        "OrgStudyId": "CMM/EM/2008"
      },
      "Organization": {
        "OrgFullName": "Andalusian Network for Design and Translation of Advanced Therapies",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis",
      "OfficialTitle": "Multicenter Clinical Trial Phase I / II Randomized, Placebo-controlled Study to Evaluate Safety and Feasibility of Therapy With Two Different Doses of Autologous Mesenchymal Stem Cells in Patients With Secondary Progressive Multiple Sclerosis Who do Not Respond to Treatment"
    },
    "StatusModule": {
      "StatusVerifiedDate": "February 2015",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "January 2010"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "June 2012",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "June 2015",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "January 25, 2010",
      "StudyFirstSubmitQCDate": "January 25, 2010",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "January 26, 2010",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "August 4, 2015",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "August 7, 2015",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Carlos III Health Institute",
            "CollaboratorClass": "OTHER_GOV"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The main purpose of this study is to evaluate the safety and feasibility of regenerative therapy with mesenchymal stem cells from adipose tissue, administered intravenously in patients with secondary progressive multiple sclerosis who do not respond to treatment."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Autoimmune Diseases",
          "Immune System Diseases",
          "Demyelinating Diseases",
          "Nervous System Diseases",
          "Demyelinating Autoimmune Diseases, CNS",
          "Autoimmune Diseases of the Nervous System"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Multiple Sclerosis",
          "Mesenchymal Stem Cells",
          "Autologous"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Quadruple",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Care Provider",
              "Investigator",
              "Outcomes Assessor"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "30",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Low dose autologous mesenchymal cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "The dose of infused cells is 10e6 cells/Kg",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Autologous mesenchymal stem cells from adipose tissue."
              ]
            }
          },
          {
            "ArmGroupLabel": "High dose",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "The dose of infused cells is 4*10e6 cells/Kg",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Autologous mesenchymal stem cells from adipose tissue."
              ]
            }
          },
          {
            "ArmGroupLabel": "Placebo Control",
            "ArmGroupType": "No Intervention"
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Other",
            "InterventionName": "Autologous mesenchymal stem cells from adipose tissue.",
            "InterventionDescription": "Intravenous infusion of autologous mesenchymal stem cells.Dose:4*10e6 cells/Kg.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "High dose"
              ]
            }
          },
          {
            "InterventionType": "Other",
            "InterventionName": "Autologous mesenchymal stem cells from adipose tissue.",
            "InterventionDescription": "Intravenous infusion of autologous mesenchymal stem cells. Dose: 10e6 cells/Kg.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Low dose autologous mesenchymal cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "To evaluate safety and tolerability related to the intravenous infusion of autologous mesenchymal stem cells",
            "PrimaryOutcomeTimeFrame": "12 months."
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "To evaluate effects on MS disease activity measured by: clinical variables, imaging variables, immunological and neurophysiologic analysis, neuropsychological and quality of life scales.",
            "SecondaryOutcomeTimeFrame": "12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients diagnosed with Multiple Sclerosis (Poser and McDonald criteria).\nSecondary progressive MS patients with EDSS ≥ 5.5 and ≤ 9.\nPatients with treatment failure defined by: no response to immunomodulators / immunosuppressants, and showing activity in the form of 1 relapse in the last year or 0.5 points in EDSS progression.\nPatients with no MS relapse and no steroid treatment within the month prior to inclusion.\nPatients who give written consent to participate in the study. -\n\nExclusion Criteria:\n\nHistory of current pathology or current laboratory results indicative of any severe disease.\nPacemaker or metallic implants that prevent MR imaging.\nInability to complete questionnaires.\nRefusal to give informed consent.\nPredicted impossibility for a biopsy of at least 30 grams of fat tissue.\nPositive screening test for HIV, Hepatitis B or Hepatitis C.\nHistory of malignancy.\nHaving been in treatment with any investigational drug or have undergone any experimental procedure in the 3 months prior to baseline.\nBody mass index> 40 kg/m2.\nPatients who have been treated with prohibited concomitant medication during the month prior to inclusion in the study.\n\nPregnancy or lactation\n\n-",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Oscar Fernandez Fernandez, MD, PhD",
            "OverallOfficialAffiliation": "Hospital Regional Universitario Carlos Haya, Málaga, Spain.",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "Guillermo Izquierdo Ayuso, MD, PhD",
            "OverallOfficialAffiliation": "Hospital Universitario Virgen Macarena, Sevilla, Spain",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Hospital Regional Universitario de Málaga",
            "LocationCity": "Málaga",
            "LocationZip": "29010",
            "LocationCountry": "Spain"
          },
          {
            "LocationFacility": "Hospital Universitario Virgen Macarena",
            "LocationCity": "Sevilla",
            "LocationZip": "41004",
            "LocationCountry": "Spain"
          }
        ]
      }
    },
    "ReferencesModule": {
      "SeeAlsoLinkList": {
        "SeeAlsoLink": [
          {
            "SeeAlsoLinkLabel": "Andalusian Molecular Biology and Regenerative Medicine Centre",
            "SeeAlsoLinkURL": "http://www.cabimer.es"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000009103",
            "ConditionMeshTerm": "Multiple Sclerosis"
          },
          {
            "ConditionMeshId": "D000009422",
            "ConditionMeshTerm": "Nervous System Diseases"
          },
          {
            "ConditionMeshId": "D000020528",
            "ConditionMeshTerm": "Multiple Sclerosis, Chronic Progressive"
          },
          {
            "ConditionMeshId": "D000003711",
            "ConditionMeshTerm": "Demyelinating Diseases"
          },
          {
            "ConditionMeshId": "D000020274",
            "ConditionMeshTerm": "Autoimmune Diseases of the Nervous System"
          },
          {
            "ConditionMeshId": "D000020278",
            "ConditionMeshTerm": "Demyelinating Autoimmune Diseases, CNS"
          },
          {
            "ConditionMeshId": "D000001327",
            "ConditionMeshTerm": "Autoimmune Diseases"
          },
          {
            "ConditionMeshId": "D000007154",
            "ConditionMeshTerm": "Immune System Diseases"
          },
          {
            "ConditionMeshId": "D000012598",
            "ConditionMeshTerm": "Sclerosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000056784",
            "ConditionAncestorTerm": "Leukoencephalopathies"
          },
          {
            "ConditionAncestorId": "D000001927",
            "ConditionAncestorTerm": "Brain Diseases"
          },
          {
            "ConditionAncestorId": "D000002493",
            "ConditionAncestorTerm": "Central Nervous System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M11212",
            "ConditionBrowseLeafName": "Multiple Sclerosis",
            "ConditionBrowseLeafAsFound": "Multiple Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14567",
            "ConditionBrowseLeafName": "Sclerosis",
            "ConditionBrowseLeafAsFound": "Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M6061",
            "ConditionBrowseLeafName": "Demyelinating Diseases",
            "ConditionBrowseLeafAsFound": "Demyelinating Diseases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3781",
            "ConditionBrowseLeafName": "Autoimmune Diseases",
            "ConditionBrowseLeafAsFound": "Autoimmune Diseases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11459",
            "ConditionBrowseLeafName": "Neoplasm Metastasis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M21466",
            "ConditionBrowseLeafName": "Multiple Sclerosis, Chronic Progressive",
            "ConditionBrowseLeafAsFound": "Secondary Progressive Multiple Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21251",
            "ConditionBrowseLeafName": "Demyelinating Autoimmune Diseases, CNS",
            "ConditionBrowseLeafAsFound": "Demyelinating Autoimmune Diseases, CNS",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9352",
            "ConditionBrowseLeafName": "Immune System Diseases",
            "ConditionBrowseLeafAsFound": "Immune System Diseases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21247",
            "ConditionBrowseLeafName": "Autoimmune Diseases of the Nervous System",
            "ConditionBrowseLeafAsFound": "Autoimmune Diseases of the Nervous System",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M27744",
            "ConditionBrowseLeafName": "Leukoencephalopathies",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4356",
            "ConditionBrowseLeafName": "Brain Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4894",
            "ConditionBrowseLeafName": "Central Nervous System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC04",
            "ConditionBrowseBranchName": "Neoplasms"
          }
        ]
      }
    }
  }
}